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In Japan annually, approximately 20 people die of anaphylaxis
caused by Hymenoptera stings.1 In particular, forestry and ﬁeld
workers are at high risk of Hymenoptera stings and may develop
occupation-related allergies after being stung. Previously, we re-
ported that 30e40% of Japanese forestry and ﬁeld workers had
speciﬁc (s)IgE to Hymenoptera venom.2 To prevent anaphylactic
shock caused by Hymenoptera stings, administration of adrena-
line is very important.3 However, there are few surveys of Hyme-
noptera stings in the occupational setting and prescription of
adrenaline injectors to affected workers. We surveyed outdoor
workers in Japan to examine the rate of prescription of adrenaline
auto-injectors.
A total of 1332 (1257 men, 75 woman) participants took part in
this study (Table 1). Forestry workers (FWs) and building contrac-
tors (BCs) were staff members of a private forest owners' cooper-
ative and a private building industry cooperative, respectively, in
Tochigi prefecture, Japan, and electrical facility ﬁeld workers
(EFFWs) were employed by Tochidenko, Tochigi, Japan. The
main work of FWs is forestation, which includes weeding,
planting, and felling of trees, and these workers are frequently
exposed to Hymenoptera stings. EFFWs and BCs also usually
work outdoors and are at a high risk of Hymenoptera stings. Ofﬁce
workers (OWs) whowork in the same area were also recruited. All
participants completed questionnaires and underwent peripheral
blood tests between September and November 2015. Fifteen vol-
unteers (13 men, 2 women; mean age, 31.5 ± 3.8 years; range,
26e48 years) who had never experienced a Hymenoptera sting
were enrolled as controls. This study was approved as No1525
and No1526 in authorization number by the Dokkyo Medical Uni-
versity Koshigaya Hospital Research Ethics Committee, and writ-
ten informed consent was obtained from each participant prior
to enrollment.
A questionnaire on the following items was administered by an
allergist: age, sex, experience of a Hymenoptera sting (yes or no)
and systemic reactions (yes or no) to a Hymenoptera sting accord-
ing to Mueller grade4 (either grade I to IV), prescription (yes, un-
known, or no) and carrying (usually, sometimes, or rarely) of an
adrenaline auto-injector, and occupation. In addition, a 10-mL pe-
ripheral blood sample was taken from each participant. Serum
was immediately extracted and sIgE antibody to Hymenoptera
venom was measured. The measurement of sIgE to wasp, hornet,
and honey bee venom was determined by Sanritsu Corporation,Peer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).Chiba, Japan. Detection of sIgE by AlaSTAT 3g Allergy (AlaSTAT),
a chemiluminescent enzyme immunoassay (CLEIA), was express-
ible in quantitative units (IUA/mL) and has a working range of
0.1e500 IUA/mL. The interpretations of positive results for Ala-
STAT are based on values  0.1 IUA/mL as described previously.5,6
Data are presented as mean ± standard deviation (S.D). The c2
test, which assessed differences in bivariate analysis and by single
logistic regression, was tested for independence and odds ratios
(ORs) with 95% conﬁdence intervals (95%CI) in prescription and car-
rying auto-injector with positive results for sIgE to either Hyme-
noptera venom between FWs and the other workers. P values of
less than 0.05 were considered to indicate statistical signiﬁcance.
Statistical analyses were performed with JMP software (Version
7.4 for MAC, SAS Institute, Cary, NC, USA).
Table 1 summarizes the characteristics of the FWs, BCs, EFFWs,
and OWs. sIgE to hornet, wasp, and honey bee venomwas0.1 IUA/
mL in 169 (44.5%), 189 (49.7%), and 43 (11.3%) FWs; 92 (16.5%), 114
(20.5%), and 33 (5.9%) BCs; 25 (12.0%), 36 (17.2%), and 8 (3.8%)
EFFWs; and 19 (10.2%), 23 (12.3%), and 7 (3.7%) OWs, respectively.
Positive results of sIgE (0.1 IUA/mL) to either Hymenoptera venom
were seen in 214 (56.3%) FWs, 143 (25.7%) BCs, 45 (21.5%) EFFWs,
and 27 (14.4%) OWs. All 15 controls had negative results for sIgE
to each Hymenoptera venom. In addition, 87 (22.9%) FWs, 18
(3.2%) BCs, 16 (7.7%) EFFWs, and 2 (1.1%) OWs had received a pre-
scription for an adrenaline auto-injector. And 312 (82.1%) FWs,
318 (57.2%) BCs, 125 (59.8%) EFFWs, and 86 (46.0%) OWs had expe-
rienced a Hymenoptera sting. In the subjects had experienced a Hy-
menoptera sting, the systemic reactions or the positive results of
either venom-sIgE were seen in 58 (18.6%) or 196 (62.8%) FWs, 39
(12.3%) or 110 (34.6%) BCs, 12 (9.6%) or 37 (29.6%) EFFWs, and 3
(3.5%) or 18 (20.9%) OWs, respectively.
Figure 1A shows the occupational setting and prescription of
adrenaline auto-injector. In workers with a positive result of
sIgE Ab to either Hymenoptera venom, the prescription of adren-
aline auto-injector was given to 71 out of 214 (33.2%) FWs, 9 of
143 (6.3%) BCs, 7 of 45 (15.6%) EFFWs, and 2 out of 27 (7.4%)
OWs. The number of FWs, BCs, EFFWs, and OWs who carry their
auto-injectors were 37 (52.1%), 7 (77.8%), 5 (71.4%), and 1 (50.0%),
respectively. The ORs for the prescription of adrenaline auto-
injector to workers with positive results of sIgE to either Hyme-
noptera venom, relative to FWs, were as follows; in EFFWs, OR
0.469 (95%CI, 0.231e0.951); in BCs, OR 0.190 (95%CI,
0.098e0.367); in OWs, OR 0.223 (95%CI, 0.058e0.859). The pre-
scription of adrenaline auto-injector to workers with positive re-
sults of sIgE to Hymenoptera venom was signiﬁcantly
(P < 0.0001, respectively) greater for FWs than other outdoorvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
Subject characteristics (n ¼ 1332).
Occupation (n) Total (1332) FWs (380) EFFWs (209) BCs (556) OWs (187)
Sex (n)
Male (%) 1257 (94.4) 374 (98.4) 207 (99.0) 549 (98.7) 127 (67.9)
Female (%) 75 (5.6) 6 (1.6) 2 (1.0) 7 (1.3) 60 (32.1)
Age (years)
10e19 26 (2) 4 (1.1) 8 (3.8) 14 (2.5) 0 (0.0)
20e29 157 (11.8) 42 (11.1) 37 (17.7) 56 (10.1) 22 (11.8)
30e39 267 (20.0) 86 (22.6) 43 (20.6) 112 (20.1) 26 (13.9)
40e49 306 (23.0) 100 (26.3) 45 (21.5) 126 (22.7) 35 (18.7)
50e19 287 (21.5) 66 (17.4) 48 (23.0) 109 (19.6) 64 (34.2)
60e69 244 (18.3) 68 (17.9) 24 (11.5) 121 (21.8) 31 (16.6)
70 45 (3.4) 14 (3.7) 4 (1.9) 18 (3.2) 9 (4.8)
Wasp-sIgE (n, mean±SD) 1.24±4.89 2.25±5.98 0.67±2.62 0.92±4.12 0.78±6.08
Negative (%) 970 (72.8) 191 (50.3) 173 (82.8) 442 (79.5) 164 (87.8)
Positive (%) 362 (27.2) 189 (49.7) 36 (17.2) 114 (20.5) 23 (12.3)
Hornet-sIgE (n, mean±SD) 0.99±4.87 2.12±6.77 0.22±0.37 0.72±4.79 0.37±1.94
Negative (%) 1027 (77.1) 211 (55.5) 184 (88.0) 464 (83.5) 168 (89.8)
Positive (%) 305 (22.9) 169 (44.5) 25 (12.0) 92 (16.5) 19 (10.2)
Hony-bee sIgE (n, mean±SD) 0.28±1.51 0.35±1.32 0.15±0.39 0.32±2.1 0.15±0.30
Negative (%) 1241 (93.2) 337 (88.7) 201 (96.2) 523 (94.1) 180 (96.3)
Positive (%) 91 (6.8) 43 (11.3) 8 (3.8) 33 (5.9) 7 (3.7)
Either venom-sIgE (n)
Negative (%) 903 (67.8) 166 (43.7) 164 (78.5) 413 (74.3) 160 (85.6)
Positive (%) 429 (32.2) 214 (56.3) 45 (21.5) 143 (25.7) 27 (14.4)
Prescriotion of adrenaline (n)
Yes (%) 123 (9.2) 87 (22.9) 16 (7.7) 18 (3.2) 2 (1.1)
No (%) 1098 (82.4) 277 (72.9) 165 (78.9) 483 (86.9) 173 (92.5)
Unknown (%) 111 (8.3) 16 (4.2) 28 (13.4) 55 (9.9) 12 (6.4)
Experience of Hymenoptera stings (n)
Yes (%) 841 (63.1) 312 (82.1) 125 (59.8) 318 (57.2) 86 (46.0)
No (%) 491 (36.9) 68 (17.9) 84 (40.2) 238 (42.8) 101 (54.0)
Out of subjects who had experienced a Hymenoptera sting
Systemic reaction (n)
Yes (%) 112 (13.3) 58 (18.6) 12 (9.6) 39 (12.3) 3 (3.5)
No (%) 729 (86.7) 254 (81.4) 113 (90.4) 279 (87.7) 83 (96.5)
Either venom-sIgE (n)
Negative (%) 480 (57.1) 116 (37.2) 88 (70.4) 208 (65.4) 68 (79.1)
Positive (%) 361 (42.9) 196 (62.8) 37 (29.6) 110 (34.6) 18 (20.9)
FWs, forestry workers; BCs, building contractors; EFFWs, electrical facility ﬁeld workers; OWs, ofﬁce workers; n, numbers; sIgE, speciﬁc IgE.
Levels of sIgE (IUA/mL) are presented as mean±standard deviation (SD).
The interpretations of positive results are based on values 0.1 IUA/mL.
The interpretations of negative results are based on values <0.1 IUA/mL.
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adrenaline auto-injector in 58 FWs, 39 BCs, 12 EFFWs, and 3
OWs who had experienced systemic reactions to a Hymenoptera
sting with the result of sIgE to either Hymenoptera venom. The
prescription of adrenaline auto-injector in subjects with a posi-
tive result of sIgE to either Hymenoptera venom was given to
28 out of 49 (57.1%) FWs, 7 of 31 (22.6%) BCs, 2 of 4 (50.0%)
EFFWs, and 1 out of 3 (33.3%) OWs. The results indicate that
workers in the private forest owners' cooperative were more
likely to be prescribed an adrenaline auto-injector compared
with other workers. However, several investigators have reported
that patients with recent severe reactions and positive venom
skin test, which is an economic method to demonstrate sIgE to
Hymenoptera venom,7 might have a 10e17% chance of a systemic
reaction to their next sting.8,9 Furthermore, patients with recent
severe reactions and positive venom skin test results might have
a 40e70% chance of systemic reaction to their next sting.8 Thus,
the prescription of an adrenaline auto-injector to outdoor
workers might be considered to be few. On the other hand,
sIgE levels decline over several years if a person does not experi-
ence a subsequent Hymenoptera sting and disappearance of sIgE
levels is thought to occur immediately after stings.9,10 Thus, if re-
sults of sIgE to Hymenoptera venom immediately after Hyme-
noptera stings are negative, they need to be re-measured aftera few weeks. Moreover, subjects who had experienced an
anaphylactic reaction due to Hymenoptera stings require the pre-
scription of an adrenaline auto-injector. In addition, although
there was no signiﬁcant differences in usually carrying their
auto-injector, compare with the percentage of the other workers
(P ¼ 0.84 to EFFWs, P ¼ 0.54 to BCs, and P ¼ 0.60 to OWs), that of
FWs tended to be less (data not shown). The results indicate that
FWs who had never experienced systemic anaphylactic reactions
despite the frequency of Hymenoptera stings might not consider
the importance of carrying the auto-injector.
In conclusion, the prescription of adrenaline auto-injector to
Japanese outdoor workers who had a positive result of sIgE to
either Hymenoptera venomwas approximately 6e33%. In addition,
the prescription of adrenaline auto-injector in these workers who
had experienced systemic reactions to a Hymenoptera sting with
a positive result of sIgE to either Hymenoptera venomwas approx-
imately 23e57%. The percentage of outdoor workers who usually
carry their auto-injector during work was approximately 52e78%.
This study suggests that the owners of the cooperative need to
think about the prescription of adrenaline auto-injector for outdoor
workers who was positive results, including a part of negative re-
sults, for sIgE Ab to Hymenoptera venom. In addition, outdoor
workers should be educated about usually carrying an adrenalin
auto-injector.
A Total (n)
1332
FWs 
380
sIgE 
Prescription 
of auto-injector 
Carrying auto-
injector
EFFWs 
207
BCs 
549
OWs
187
No 
136 (63.6%)
Unknown
7 (3.3%)
* Yes
71 (33.2%)
No 
35 (77.8%)
Unknown
3 (6.7%)
Yes
7 (15.6%)
No 
25 (92.6%)
Unknown
0 (0.0%)
Yes
2 (7.4%)
Usually 
37/71 (52.1%)
Sometimes
11/71(15.5%)
Rarely
23/71(32.4%)
Usually 
5/16 (31.3%)
Sometimes
5/16 (31.3%)
Rarely
6/16 (37.4%)
Usually 
5/7 (71.4%)
Sometimes
0/7 (0.0%)
Rarely
3/7 (28.6%)
Usually 
3/9 (33.3%)
Sometimes
1/9 (11.1%)
Rarely
5/9 (55.6%)
Usually 
7/9 (77.8%)
Sometimes
0/9 (0.0%)
Rarely
2/9 (22.2%)
Usually 
1/2 (50.0%)
Sometimes
0/2 (0.0%)
Rarely
1/2 (50.0%)
No 
141 (84.9%)
Unknown
9 (5.4%)
Yes
16 (9.6%)
No 
130 (79.3%)
Unknown
25 (15.2%)
Yes
9 (5.5%)
No 
120 (83.9%)
Unknown
14 (9.8%)
Yes
9 (6.3%)
No 
370 (89.6%)
Unknown
34 (8.2%)
Yes
9 (2.2%)
Usually 
2/9 (22.2%)
Sometimes
3/9 (33.3%)
Rarely
4/9 (44.4%)
Usually 
N.D.
Sometimes
N.D.
Rarely
N.D.
No 
148 (92.5%)
Unknown
12 (7.5%)
Yes
0 (0.0%)
Positive 
214 (56.3%)
Negative 
166 (43.7%)
Negative 
164 (78.5%)
Positive 
143 (25.7%)
Negative 
413 (74.3%)
Positive 
27 (14.4%)
Negative 
160 (85.6%)
Positive
45 (21.5%)
sIgE 
Prescription 
of auto-injector 
B
FWs 
58
Positive 
49 (84.5%)
No 
21 (42.9%)
Unknown
0 (0.0%)
Yes
28 (57.1%)
Negative 
9 (15.5%)
EFFWs 
12
Positive
4 (33.3%)
No 
2 (50.0%)
Unknown
0 (0.0%)
Yes
2 (50.0%)
Negative 
8 (66.7%)
Positive 
31 (79.5%)
Negative 
8 (20.5%)
BCs 
39
Positive 
3 (100%)
No 
2 (66.7%)
Unknown
0 (0.0%)
Yes
1 (33.3%)
Negative 
0 (0.0%)
OWs
3
No 
6 (66.7%)
Unknown
0 (0.0%)
Yes
3 (33.3%)
No 
8 (100%)
Unknown
0 (0.0%)
Yes
0 (0.0%)
No 
19 (61.3%)
Unknown
5 (16.1%)
Yes
7 (22.6%)
No 
7 (87.5%)
Unknown
1 (12.5%)
Yes
0 (0.0%)
N.A.
Subjects who had experienced systemic 
reactions to a Hymenoptera sting 
Total (n) 
112 
Fig. 1. A. Prescription and carrying of adrenaline injector by FWs, BCs, EFFWs, and OWs with a positive result of sIgE to either Hymenoptera venom in this study. *P < 0.0001,
compared with prescription of adrenaline auto-injector to EFFWs, BCs, or OWs. N.D., not done. B. Prescription of adrenaline auto-injector by FWs, BCs, EFFWs, and OWs who
had experienced systemic reactions to a Hymenoptera sting with the result of sIgE to either Hymenoptera venom in this study. N.A., not applicable.
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